Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

LD-2 disclosure · 1st Quarter - Report

INSMED INCORPORATED

via RUBICON ADVISORS, LLC

1st Quarter (Jan 1 - Mar 31) · 2011Posted Apr 11, 2011Filing document ↗LDA record ↗

Income$23Kfee reported

Client

Name: INSMED INCORPORATED
Description: Pharmaceutical
Location: * Undetermined

Registrant

Firm: RUBICON ADVISORS, LLC
Description: Lobbying firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Pharmacy
Generic Biologics S. 1695 Affordable Health Care Choices Act
LobbyistsKATHY KULKARNI · WILLIAM BURKE · TODD SMITH
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

INSMED INCORPORATED — Lobbying — Receipts Report